2025

Impact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing Thrombectomy
Fladt J, Benali F, Jaroenngarmsamer T, Bala F, Singh N, Nogueira R, McTaggart R, Demchuk A, Poppe A, Buck B, Tymianski M, Hill M, Goyal M, Ganesh A
NEUROLOGY. 2025;104(10):e213619.

2024

Development and prospective clinical validation of a convolutional neural network for automated detection and segmentation of focal cortical dysplasias
Chanra V, Chudzinska A, Braniewska N, Silski B, Holst B, Sauvigny T, Stodieck S, Pelzl S, House P
EPILEPSY RES. 2024;202:107357.

2021

Automated detection and segmentation of focal cortical dysplasias (FCDs) with artificial intelligence: Presentation of a novel convolutional neural network and its prospective clinical validation
House P, Kopelyan M, Braniewska N, Silski B, Chudzinska A, Holst B, Sauvigny T, Martens T, Stodieck S, Pelzl S
EPILEPSY RES. 2021;172:106594.

2020

Comparison of acetylsalicylic acid and clopidogrel non-responsiveness assessed by light transmittance aggregometry and PFA-100® in patients undergoing neuroendovascular procedures
Rolling C, Tomada J, Frölich A, Holst B, Holstein K, Voigtländer M, Janjetovic S, Haddad M, Renné T, Fiehler J, Bokemeyer C, Rolling T, Langer F
CLIN CHEM LAB MED. 2020;59(2):383-392.

2019

Fatal PCR-negative herpes simplex virus-1 encephalitis with GABAA receptor antibodies
Schuster S, Abrante L, Matschke J, Lütgehetmann M, Holst B, Gelderblom M, Braass H, Leypoldt F, Magnus T
NEUROL-NEUROIMMUNOL. 2019;6(6):.

2018

Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data
Campbell B, van Zwam W, Goyal M, Menon B, Dippel D, Demchuk A, Bracard S, White P, Dávalos A, Majoie C, van der Lugt A, Ford G, de la Ossa N, Kelly M, Bourcier R, Donnan G, Roos Y, Bang O, Nogueira R, Devlin T, van den Berg L, Clarençon F, Burns P, Carpenter J, Berkhemer O, Yavagal D, Pereira V, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis S, Jansen O, Rubiera M, Urra X, Micard E, Lingsma H, Naggara O, Brown S, Guillemin F, Muir K, van Oostenbrugge R, Saver J, Jovin T, Hill M, Mitchell P
LANCET NEUROL. 2018;17(1):47-53.

Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy
Dührsen L, Sauvigny T, House P, Stodieck S, Holst B, Matschke J, Schön G, Westphal M, Martens T
J NEUROSURG. 2018;128(6):1668-1673.

2017

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
Hodecker S, Stellmann J, Rosenkranz S, Young K, Holst B, Friese M, Heesen C
NEUROL-NEUROIMMUNOL. 2017;4(2):e328.

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
Hodecker S, Stürner K, Becker V, Elias-Hamp B, Holst B, Friese M, Heesen C
NEUROL-NEUROIMMUNOL. 2017;4(2):e325.

T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis
Thaler C, Faizy T, Sedlacik J, Holst B, Stürner K, Heesen C, Stellmann J, Fiehler J, Siemonsen S
AM J NEURORADIOL. 2017;38(2):264-269.

Letzte Aktualisierung aus dem FIS: 15.03.2026 - 05:50 Uhr